Metabolic correction of experimental diabetic retinopathy
Introduction. Diabetic retinopathy (DR) is diagnosed in 50% of the total number of patients suffering from type 1 diabetes mellitus with diabetes duration of over 10 years and in 75-90% of patients with diabetes duration over 15 years. Purpose. To ground the possibility of using arginine for corr...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Ukrainian Society of Ophthalmologists
2017-12-01
|
Series: | Journal of Ophthalmology |
Subjects: | |
Online Access: | https://www.ozhurnal.com/en/archive/2017/6/12-fulltext |